시장보고서
상품코드
1630673

주입 요법 시장 규모, 점유율, 성장 분석 : 제품별, 적응증별, 치료법별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Infusion Therapy Market Size, Share, Growth Analysis, By Product (Infusion Pumps, Infusion Set), By Indication (Cancer, Gastrointestinal Diseases/Disorders), By Therapy, By Application, By End-user, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 주입 요법 시장 규모는 2023년에 444억 5,000만 달러로 평가되며, 2024년 474억 3,000만 달러에서 2032년에는 796억 8,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 6.7%로 성장할 전망입니다.

세계의 주입 요법 시장은 인구 고령화와 만성질환의 유병률 증가에 힘입어 크게 성장하고 있습니다. 수액이나 약물을 혈류에 직접 주입하는 이 치료법은 특히 항생제, 화학요법, 영양 보충 등에 빠르고 효과적인 치료를 제공합니다. 환자 입장에서는 정확한 투약과 약효 연장, 투약 횟수 감소, 외래 및 재택 치료가 가능하다는 장점이 있습니다. 이러한 장점에도 불구하고 주입 요법은 감염 및 부작용 등의 위험이 있으며, 숙련된 관리가 필요합니다. 수액 장비의 기술 발전과 재택치료에 대한 수요 증가는 시장 확대를 촉진하는 데 매우 중요합니다. 전반적으로 수액 치료 시장은 효율적인 헬스케어 솔루션에 대한 수요 증가에 따라 성장세를 유지하고 있습니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요의 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석

주입 요법 시장 규모 : 제품별

  • 시장 개요
  • 주입 펌프
    • 휴대용 주입 펌프
    • 고정형 주입 펌프
    • 시린지 주입 펌프
    • 일회용 펌프
    • 대용량 펌프
    • 엘라스토머 펌프
  • 주입 세트
  • 액세서리

주입 요법 시장 규모 : 적응증별

  • 시장 개요
  • 소화기 질환/장애
  • 울혈성심부전
  • 류마티스 관절염
  • 혈우병
  • 면역 부전
  • 기타

주입 요법 시장 규모 : 치료법별

  • 시장 개요
  • 항생제/항바이러스제
  • 항응고약
  • 항구토제
  • 혈액 성분 자극 인자
  • 화학요법
  • 영양
  • 수분 보급
  • 통증 관리

주입 요법 시장 규모 : 용도별

  • 시장 개요
  • 화학요법
  • 당뇨병
  • 소화기 질환
  • 통증 관리
  • 기타

주입 요법 시장 규모 : 최종사용자별

  • 시장 개요
  • 병원
  • 외래 수술 센터
  • 클리닉
  • 홈케어 시설

주입 요법 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 개요
    • 회사 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024)

주요 기업 개요

  • Option Care Health Inc.(United States)
  • Baxter International Inc.(United States)
  • ICU Medical, Inc.(United States)
  • B. Braun Melsungen AG(Germany)
  • Terumo Corporation(Japan)
  • Moog Inc.(United States)
  • Fresenius SE & Co. KGaA(Germany)
  • Smiths Medical(United Kingdom)
  • JMS Co. Ltd.(Japan)
  • Caesarea Medical Electronics(Israel)
  • CareFusion Corporation(United States)
  • Poly Medicure Limited(India)
  • Nipro Corporation(Japan)
  • Medtronic plc(Ireland)
  • Becton, Dickinson and Company(BD)(United States)
  • 3M Company(United States)
  • Teleflex Incorporated(United States)
  • Edwards Lifesciences Corporation(United States)
  • Coloplast A/S(Denmark)
  • Convatec Group plc(United Kingdom)

결론과 권장사항

KSA 25.02.24

Global Infusion Therapy Market size was valued at USD 44.45 billion in 2023 and is poised to grow from USD 47.43 billion in 2024 to USD 79.68 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The global infusion therapy market is witnessing substantial growth, fueled by an aging population and the rising prevalence of chronic diseases. This therapy, which involves the direct delivery of fluids and medications into the bloodstream, provides rapid and effective treatment, particularly for antibiotics, chemotherapy, and nutritional support. Patients benefit from precise dosing and prolonged medication effects, reducing the frequency of administration and enabling outpatient or home treatment options. Despite its advantages, infusion therapy presents risks, including infection and side effects, necessitating skilled administration. Technological advancements in infusion devices and the growing demand for home healthcare are pivotal in driving market expansion. Overall, the infusion therapy market remains poised for growth, addressing the increasing needs for efficient healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infusion Therapy Market Segmental Analysis

Global Infusion Therapy Market is segmented by Product, Indication, Therapy, Application, End-user and region. Based on Product, the market is segmented into Infusion Pumps, Infusion Set and Accessories. Based on Indication, the market is segmented into Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies and Others. Based on Therapy, the market is segmented into Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration and Pain Management. Based on Application, the market is segmented into Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain management and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infusion Therapy Market

The global infusion therapy market is significantly driven by the rising incidence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases. As these health conditions continue to affect a larger portion of the population, the need for effective treatment options, particularly in the form of infusion therapy products and services, has surged. This growing demand is prompting healthcare providers to expand their infusion therapy offerings, leading to innovations and advancements in technology that enhance patient care. Consequently, the infusion therapy market is experiencing robust growth, fueled by the increasing requirements for targeted and effective treatment strategies for chronic disease management.

Restraints in the Global Infusion Therapy Market

The Global Infusion Therapy market faces significant constraints, primarily due to the elevated expenses linked to infusion therapy products and services. This financial burden poses a major challenge, particularly in developing nations where healthcare access is already restricted. The high costs can limit the adoption and utilization of essential infusion therapies, hindering patient care and overall market growth. As a result, many potential users may be unable to afford the necessary treatments, further exacerbating healthcare inequities and limiting the market's expansion in regions that most require these critical services. Addressing these financial barriers is essential for market advancement.

Market Trends of the Global Infusion Therapy Market

The Global Infusion Therapy market is experiencing a notable shift towards home infusion therapy, driven by an increasing preference among patients for home-based healthcare services. This trend reflects a desire for enhanced convenience, comfort, and cost-efficiency, as patients seek to avoid the hospital environment whenever possible. As a result, healthcare providers are adapting to this demand by offering advanced home infusion solutions, empowering patients with autonomy over their treatment while reducing hospital congestion. The surge in chronic diseases and a growing aging population further bolster this market segment, marking a significant evolution in the delivery of infusion therapies worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Infusion Therapy Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Infusion Pumps
    • Ambulatory Infusion Pumps
    • Stationary Infusion Pumps
    • Syringe Infusion Pumps
    • Disposable Pumps
    • Large Volume Pumps
    • Elastomeric pumps
  • Infusion Set
  • Accessories

Global Infusion Therapy Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Cancer
  • Gastrointestinal Diseases/Disorders
  • Congestive Heart Failure
  • Rheumatoid Arthritis
  • Hemophilia
  • Immune Deficiencies
  • Others

Global Infusion Therapy Market Size by Therapy & CAGR (2025-2032)

  • Market Overview
  • Antibiotic/Antiviral
  • Anti-coagulation
  • Anti-emetics
  • Blood Component Stimulating Factor
  • Chemotherapy
  • Nutrition
  • Hydration
  • Pain Management

Global Infusion Therapy Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Chemotherapy
  • Diabetes
  • Gastrointestinal Diseases
  • Pain management
  • Others

Global Infusion Therapy Market Size by End-user & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Homecare Settings

Global Infusion Therapy Market Size & CAGR (2025-2032)

  • North America (Product, Indication, Therapy, Application, End-user)
    • US
    • Canada
  • Europe (Product, Indication, Therapy, Application, End-user)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Indication, Therapy, Application, End-user)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Indication, Therapy, Application, End-user)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Indication, Therapy, Application, End-user)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Option Care Health Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moog Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius SE & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JMS Co. Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caesarea Medical Electronics (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CareFusion Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Poly Medicure Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Convatec Group plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제